Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
904.61
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
771
Open
904.61
Bid (Size)
907.70 (1)
Ask (Size)
909.00 (1)
Prev. Close
904.61
Today's Range
904.61 - 904.61
52wk Range
434.34 - 909.42
Shares Outstanding
N/A
Dividend Yield
0.50%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Reasons Why Eli Lilly's Stock Likely Hasn't Peaked
Today 4:35 EDT
The stock may seem expensive right now, but that may not be the case in a few years.
Via
The Motley Fool
Alphabet Among Stocks Hitting All-Time High Tuesday: See Which Stocks Just Came On IBD's Top Stock Screens
June 25, 2024
Google-parent Alphabet hit a fresh high at 184.03 Tuesday. Its earnings rose the past year to a 53% surge to $1.74 per share last quarter.
Via
Investor's Business Daily
Performance
YTD
+52.75%
+52.75%
1 Month
+11.98%
+11.98%
3 Month
+16.74%
+16.74%
6 Month
+58.52%
+58.52%
1 Year
+99.80%
+99.80%
More News
Read More
Novo Nordisk's Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows
June 25, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 25, 2024
Via
Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
June 25, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
This Is What Whales Are Betting On Eli Lilly and Co
June 25, 2024
Via
Benzinga
NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug
June 25, 2024
Via
InvestorPlace
1 Supercharged Vanguard Index Fund to Buy Before It Soars 174%, According to a Wall Street Analyst
June 25, 2024
Via
The Motley Fool
Topics
ETFs
Stocks
Exposures
US Equities
What's Going On With Eli Lilly Shares Monday?
June 24, 2024
Via
Benzinga
Why ResMed Shares Are Trading Lower Monday
June 24, 2024
Via
Benzinga
Will Novo Nordisk Building Fires Serve As A Catalyst For Eli Lilly? Redditors See A Stock Split For US Company 'Very Likely'
June 24, 2024
Via
Benzinga
Exposures
Product Safety
10 Health Care Stocks Whale Activity In Today's Session
June 24, 2024
Via
Benzinga
The Top 3 Sectors Poised For Growth This Summer
June 24, 2024
Via
MarketBeat
Topics
ETFs
ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings
June 24, 2024
Via
InvestorPlace
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
June 24, 2024
Via
Investor's Business Daily
Eli Lilly's Zepbound For Weight Loss Shows Disease Resolution In Obese Sleep Apnea Patients, Lays Further Groundwork For Label Expansion
June 24, 2024
Via
Benzinga
Exposures
Product Safety
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
June 22, 2024
Via
Talk Markets
MarketBeat Week in Review – 6/17 - 6/21
June 22, 2024
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
3 Biotech Stocks to Buy Now: June 2024
June 21, 2024
Via
InvestorPlace
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Via
Benzinga
Lawsuit Could Challenge Trust In Ozempic And Other Popular Weight Loss Drugs
June 21, 2024
Via
Talk Markets
Topics
Lawsuit
Exposures
Financial
Legal
Pre-Market Movers - June 21, 2024
June 21, 2024
Via
Talk Markets
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
June 21, 2024
Via
Benzinga
Hype Busters: 3 Overvalued Stocks Ready for a Reality Check
June 21, 2024
Via
InvestorPlace
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
June 21, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.